These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28069650)

  • 41. Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia.
    Tsai CY; Lee CH; Chen IL
    BMC Infect Dis; 2021 May; 21(1):437. PubMed ID: 33980167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. agr functionality affects clinical outcomes in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia.
    Kang CK; Kim YK; Jung SI; Park WB; Song KH; Park KH; Choe PG; Jang HC; Lee S; Kim YS; Kwak YG; Kwon KT; Kiem S; Kim CJ; Kim ES; Kim HB;
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2187-2191. PubMed ID: 28639163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
    Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
    Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality Improvement of Staphylococcus aureus Bacteremia Management and Predictors of Relapse-free Survival.
    Townsend J; Pelletier J; Peterson G; Matulevicius S; Sreeramoju P
    Am J Med; 2016 Feb; 129(2):195-203. PubMed ID: 26519616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia.
    Minejima E; Bensman J; She RC; Mack WJ; Tuan Tran M; Ny P; Lou M; Yamaki J; Nieberg P; Ho J; Wong-Beringer A
    Crit Care Med; 2016 Apr; 44(4):671-9. PubMed ID: 26540400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Park HJ; Kim SH; Kim MJ; Lee YM; Park SY; Moon SM; Park KH; Chong YP; Lee SO; Choi SH; Woo JH; Kim YS
    J Infect; 2012 Dec; 65(6):505-12. PubMed ID: 22902942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacterial factors influencing the mortality for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia.
    Zarakolu P; Metan G; Ünal S; Karahan ZC; Tekeli A
    Infect Dis (Lond); 2016 Aug; 48(8):649-50. PubMed ID: 27167630
    [No Abstract]   [Full Text] [Related]  

  • 48. Using MRSA Screening Tests To Predict Methicillin Resistance in Staphylococcus aureus Bacteremia.
    Butler-Laporte G; Cheng MP; Cheng AP; McDonald EG; Lee TC
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7444-7448. PubMed ID: 27736763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
    Bigseth RS; Sandholdt H; Petersen A; Østergaard C; Benfield T; Thorlacius-Ussing L
    Microbiol Spectr; 2022 Jun; 10(3):e0153021. PubMed ID: 35438533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of vancomycin minimum inhibitory concentration on mortality among critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia.
    Woods CJ; Chowdhury A; Patel VM; Shorr AF
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1246-9. PubMed ID: 23143364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Goldberg E; Paul M; Talker O; Samra Z; Raskin M; Hazzan R; Leibovici L; Bishara J
    J Antimicrob Chemother; 2010 Aug; 65(8):1779-83. PubMed ID: 20507860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
    Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study.
    Forsblom E; Kakriainen A; Ruotsalainen E; Järvinen A
    Infection; 2018 Dec; 46(6):837-845. PubMed ID: 30194636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Should all adjunctive corticosteroid therapy be avoided in the management of hemodynamically stabile Staphylococcus aureus bacteremia?
    Forsblom E; Nurmi AM; Ruotsalainen E; Järvinen A
    Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):471-9. PubMed ID: 26768583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statin Use and Risk of Community-Acquired Staphylococcus aureus Bacteremia: A Population-Based Case-Control Study.
    Smit J; López-Cortés LE; Thomsen RW; Schønheyder HC; Nielsen H; Frøslev T; Rodríguez-Bãno J; Søgaard M
    Mayo Clin Proc; 2017 Oct; 92(10):1469-1478. PubMed ID: 28982483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Statin use and kidney cancer outcomes: A propensity score analysis.
    Nayan M; Finelli A; Jewett MAS; Juurlink DN; Austin PC; Kulkarni GS; Hamilton RJ
    Urol Oncol; 2016 Nov; 34(11):487.e1-487.e6. PubMed ID: 27427224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
    Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
    J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
    Yaw LK; Robinson JO; Ho KM
    Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia.
    Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Warren SJ; Gao W; Johnson PD; Howden BP
    Clin Microbiol Infect; 2013 Dec; 19(12):1163-8. PubMed ID: 23441652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.